Literature DB >> 25723616

Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission.

Patricia D Jones1, Michael D Kappelman, Christopher F Martin, Wenli Chen, Robert S Sandler, Millie D Long.   

Abstract

BACKGROUND: Although exercise impacts quality of life in patients with inflammatory bowel disease, little is known about its role in disease activity. Among patients with inflammatory bowel disease in remission, we aimed to evaluate the association between exercise and subsequent active disease.
METHODS: We performed a prospective study using the Crohn's and Colitis Foundation of America Partners' internet-based cohort of individuals with self-reported inflammatory bowel disease. We identified participants in remission, defined as short Crohn's disease activity index <150 or simple clinical colitis activity index ≤2. The primary exposure was exercise status, measured using the validated Godin leisure-time activity index. The primary study outcome, assessed after 6 months, was active disease defined using the above disease activity index thresholds. We used bivariate and multivariate analyses to describe the independent association between exercise and risk of active disease.
RESULTS: We identified 1308 patients with Crohn's disease (CD) and 549 with ulcerative or indeterminate colitis (UC/IC) in remission, of whom 227 (17.4%) with CD and 135 (24.6%) with UC/IC developed active disease after 6 months. Higher exercise level was associated with decreased risk of active disease for CD (adjusted risk ratio: 0.72, 95% confidence interval: 0.55-0.94) and UC/IC (adjusted risk ratio: 0.78, 95% confidence interval: 0.54-1.13).
CONCLUSIONS: In patients with CD in remission, those with higher exercise levels were significantly less likely to develop active disease at 6 months. In patients with UC/IC in remission, patients with higher exercise levels were less likely to develop active disease at 6 months; however this was not statistically significant.

Entities:  

Mesh:

Year:  2015        PMID: 25723616      PMCID: PMC4402239          DOI: 10.1097/MIB.0000000000000333

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  46 in total

Review 1.  Bone loss in Crohn's disease: exercise as a potential countermeasure.

Authors:  Naomi Lee; Graham Radford-Smith; Dennis R Taaffe
Journal:  Inflamm Bowel Dis       Date:  2005-12       Impact factor: 5.325

2.  Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.

Authors:  Millie D Long; Wallace V Crandall; Ian H Leibowitz; Lynn Duffy; Fernando del Rosario; Sandra C Kim; Mark J Integlia; James Berman; John Grunow; Richard B Colletti; Bess T Schoen; Ashish S Patel; Howard Baron; Esther Israel; George Russell; Sabina Ali; Hans H Herfarth; Christopher Martin; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2010-12-17       Impact factor: 5.325

3.  Exercise and associated dietary extremes impact on gut microbial diversity.

Authors:  Siobhan F Clarke; Eileen F Murphy; Orla O'Sullivan; Alice J Lucey; Margaret Humphreys; Aileen Hogan; Paula Hayes; Maeve O'Reilly; Ian B Jeffery; Ruth Wood-Martin; David M Kerins; Eamonn Quigley; R Paul Ross; Paul W O'Toole; Michael G Molloy; Eanna Falvey; Fergus Shanahan; Paul D Cotter
Journal:  Gut       Date:  2014-06-09       Impact factor: 23.059

4.  Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls.

Authors:  Katharina J Werkstetter; Jennifer Ullrich; Stephanie B Schatz; Christine Prell; Berthold Koletzko; Sibylle Koletzko
Journal:  J Crohns Colitis       Date:  2012-01-09       Impact factor: 9.071

5.  Occupational distribution of inflammatory bowel disease among German employees.

Authors:  A Sonnenberg
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

6.  Evaluation of densitometric bone-muscle relationships in Crohn's disease.

Authors:  Marina Mauro; David Armstrong
Journal:  Bone       Date:  2007-03-07       Impact factor: 4.398

7.  Exercise capacity in pediatric patients with inflammatory bowel disease.

Authors:  Hilde E Ploeger; Tim Takken; Boguslaw Wilk; Robert M Issenman; Ryan Sears; Soni Suri; Brian W Timmons
Journal:  J Pediatr       Date:  2010-12-10       Impact factor: 4.406

8.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

9.  Low-intensity exercise improves quality of life in patients with Crohn's disease.

Authors:  Victor Ng; Wanda Millard; Constance Lebrun; John Howard
Journal:  Clin J Sport Med       Date:  2007-09       Impact factor: 3.638

10.  Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Xiaomei Liao; Leslie M Higuchi; Charles S Fuchs; Donna Spiegelman; James M Richter; Joshua R Korzenik; Andrew T Chan
Journal:  BMJ       Date:  2013-11-14
View more
  18 in total

Review 1.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 2.  AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review.

Authors:  Jean-Frederic Colombel; Andrea Shin; Peter R Gibson
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

3.  Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease.

Authors:  Wolfgang Alexander Seeger; Juliane Thieringer; Philip Esters; Benjamin Allmendinger; Jürgen Stein; Hermann Schulze; Axel Dignass
Journal:  United European Gastroenterol J       Date:  2020-06-25       Impact factor: 4.623

4.  High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Millie D Long; Michael D Kappelman; Christopher F Martin; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2019-06-18       Impact factor: 5.325

5.  The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Authors:  Steven C Lin; Adam S Cheifetz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

6.  The gut microbiota and nervous system: Age-defined and age-defying.

Authors:  Annelise A Madison; Janice K Kiecolt-Glaser
Journal:  Semin Cell Dev Biol       Date:  2021-01-06       Impact factor: 7.499

7.  Physical Activity in Patients with Inflammatory Bowel Disease: A Cross-Sectional Study.

Authors:  Georgina Fagan; Hamish Osborne; Michael Schultz
Journal:  Inflamm Intest Dis       Date:  2021-02-24

8.  Refractory neutrophils and monocytes in patients with inflammatory bowel disease after repeated bouts of prolonged exercise.

Authors:  Roy Spijkerman; Lillian Hesselink; Carlo Bertinetto; Coen C W G Bongers; Falco Hietbrink; Nienke Vrisekoop; Luke P H Leenen; Maria T E Hopman; Jeroen J Jansen; Leo Koenderman
Journal:  Cytometry B Clin Cytom       Date:  2021-03-08       Impact factor: 3.248

9.  Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.

Authors:  Bharati Kochar; Molly Aldridge; Suzanne Follan Cook; Renee Bright; Meaghan Mallette; Heather Moniz; Samir A Shah; Neal S LeLeiko; Jason Shapiro; Bruce E Sands; Wenli Chen; Elizabeth Jaeger; Joseph Galanko; Millie D Long; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  J Med Internet Res       Date:  2016-06-03       Impact factor: 5.428

Review 10.  The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease.

Authors:  Steven Nicolaides; Abhinav Vasudevan; Tony Long; Daniel van Langenberg
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.